COVID-19 pandemic sees increased consults for alcohol-related GI and liver diseases

  Bethesda, MD, USA (May 14, 2021) — Inpatient consults for alcohol-related gastrointestinal (GI) and liver diseases have surged since the beginning of the COVID-19 pandemic and remained elevated, according to research selected for presentation at Digestive Disease Week® (DDW) 2021. The proportion of patients that required inpatient endoscopic interventions for their alcohol-related GI and
WEITERLESEN »

The eyes offer a window into Alzheimer’s disease

  San Francisco, Cal., USA (May 14, 2021) — While it has been said that the eyes are a window to the soul, a new study shows they could be a means for understanding diseases of the brain. According to new research by scientists at the UCSF Weill Institute for Neurosciences, retinal scans can detect
WEITERLESEN »

Ventilating the rectum to support respiration

  Tokyo, Japan (May 14, 2021) — Oxygen is crucial to many forms of life. Its delivery to the organs and tissues of the body through the process of respiration is vital for most biological processes. Now, researchers at Tokyo Medical and Dental University (TMDU) have shown that oxygen can be delivered through the wall
WEITERLESEN »

Screening for ovarian cancer did not reduce deaths

  London, UK (May 13, 2021) — A large-scale randomised trial of annual screening for ovarian cancer, led by UCL researchers, did not succeed in reducing deaths from the disease, despite one of the screening methods tested detecting cancers earlier. Results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) have been published in
WEITERLESEN »

Fatigue, mood disorders associated with post-COVID-19 syndrome

  ROCHESTER, Minn., USA (May 12, 2021) — Patients diagnosed with post-COVID-19 syndrome, also known as “PCS,” “COVID-19 long-haul syndrome” and “Post-Acute Sequelae of SARS COV-2,” experience symptoms such as mood disorders, fatigue and perceived cognitive impairment that can negatively affect returning to work and resuming normal activities, according to a Mayo Clinic study published
WEITERLESEN »

New material to treat wounds can protect against resistant bacteria

  GOTHENBURG, SWEDEN (May 11, 2021) — Researchers at Chalmers University of Technology, Sweden, have developed a new material that prevents infections in wounds – a specially designed hydrogel, that works against all types of bacteria, including antibiotic-resistant ones. The new material offers great hope for combating a growing global problem. The World Health Organization
WEITERLESEN »

Gout treatment success doubled by combining two drugs, study finds

  Ann Arbor, Michigan, USA (May 11, 2021) — By combining two medications, researchers at Michigan Medicine optimized a therapy for people with gout, a condition that causes severe damage and disability if left untreated. The study revealed how a second drug taken orally more than doubled the effectiveness of Pegloticase, an intravenous gout treatment
WEITERLESEN »

This stinks: New research finds sense of smell and pneumonia linked

This stinks: New research finds sense of smell and pneumonia linked   EAST LANSING, Mich., USA (May 11, 2021) — An acute loss of smell is one of the most common symptoms of COVID-19, but for two decades it has been linked to other maladies among them Parkinson’s disease and dementia. Now, a poor sense
WEITERLESEN »

Study examines connection between oral and general health in patients with diabetes

  Leawood, KS, USA (May 11, 2021) — Individuals with diabetes are at greater risk of developing oral health issues, like gum disease, yet care for these linked health issues are usually disconnected, split between primary care and dental care. A research team from the University of Amsterdam developed an intervention that provided primary care-based
WEITERLESEN »

Microneedle patch delivers antibiotics locally in the skin

  Stockholm, Sweden (May 10, 2021) — MRSA skin infections are often treated with intravenous injection of antibiotics, which can cause significant side effects and promote the development of resistant bacterial strains. To solve these problems, researchers at Karolinska Institutet in Sweden are developing a microneedle patch that delivers antibiotics directly into the affected skin
WEITERLESEN »

New theory may revolutionize treatment of endometriosis

  Vancouver, Canada (May 11, 2021) — Endometriosis, a disease found in up to 10 per cent of women, has been enigmatic since it was first described. A new theory developed by researchers at Simon Fraser University suggests a previously overlooked hormone — testosterone — has a critical role in its development. The research could
WEITERLESEN »

Perinatal patients, nurses explain how hospital pandemic policies failed them

  Seattle, WA, USA (April 7, 2021) — With a lethal, airborne virus spreading fast, hospitals had to change how they treated patients and policies for how caregivers provided that treatment. But for maternity patients and nurses some of those changes had negative outcomes, according to a new University of Washington study. “We found that
WEITERLESEN »

Johns Hopkins Medicine expert creates comprehensive guide to new diabetes drugs

Diabetes specialist Rita Kalyani outlines the current standards of care for diabetes management   Baltimore, MA, USA (April 7, 2021) — New medicines for people who have diabetes seem to pop up all the time. Drugs that help the body break down carbohydrates, drugs that increase excretion of glucose in the urine, drugs that help
WEITERLESEN »

An amyloid link between Parkinson’s disease and melanoma

  WASHINGTON, USA (April 7, 2021) — On the surface, Parkinson’s disease — a neurodegenerative disorder — and melanoma — a type of skin cancer — do not appear to have much in common. However, for nearly 50 years, doctors have recognized that Parkinson’s disease patients are more likely to develop melanoma than the general
WEITERLESEN »

Ultrasensitive, rapid diagnostic detects Ebola earlier than gold standard test

Portable platform detects early biomarkers of the Ebola virus faster than PCR, the current industry standard   DURHAM, N.C., USA (April 7, 2021) — An interdisciplinary team of scientists at Duke University has developed a highly sensitive and rapid diagnostic test for Ebola virus (EBOV) infection. In monkeys infected with Ebola, this diagnostic, called the
WEITERLESEN »

Paranoia therapy app SlowMo helps people ‘slow down’ and manage their fears

A clinical trial has revealed that a new digitally supported therapy effectively supports people to manage paranoia to help them get on with life   London, UK (April 7, 2021) — A new clinical trial from King’s College London’s Institute of Psychiatry, Psychology, & Neuroscience, in collaboration with Oxford University, Oxford Health NHS Foundation Trust,
WEITERLESEN »

Conspiracy theories and cognitive biases in the COVID-19 pandemic

  Basel, Switzerland (April 7, 2021) — Conspiracy theories appear to be increasing in popularity as the Covid-19 pandemic continues. But to what extent do people really agree with them, and what is the association with cognitive biases? A research team from the University of Basel studied these questions in German-speaking Switzerland and Germany. Periods
WEITERLESEN »

New Lyme disease test distinguishes between early and late-stage disease

New test targets genetic sequences in Lyme-causing bacteria and is highly sensitive, detecting just one bacterial cell in a blood sample   (April 7, 2021) — For those who live in an area blighted by ticks, the threat of Lyme disease can cast a shadow over the joy of spring and summer. These blood-sucking arachnids
WEITERLESEN »

Study shows why crossing obstacles is difficult for patients with Parkinson’s disease

  Bauru, Brazil (April 7, 2021) – A multidisciplinary research group affiliated with the Department of Physical Education’s Human Movement Laboratory (Movi-Lab) at São Paulo State University (UNESP) in Bauru, Brazil, measured step length synergy while crossing obstacles in patients with Parkinson’s disease and concluded that it was 53% lower than in healthy subjects of
WEITERLESEN »

Cost-effective, easily manufactured ventilators for COVID-19 patients

The Mechanical Ventilator Milano design helps overcome the ventilator shortage, aids with the respiratory effects of the pandemic.   WASHINGTON, USA (March 23, 2021) — Scientists have been working for the past year to find ways to curb the effects of the COVID-19 pandemic. Though it is outside their typical realm of study, physicists have
WEITERLESEN »

New diagnostic tool for the management of patients with sepsis

  Hennigsdorf/Berlin, Germany (March 23, 2021) — Diagnostics company SphingoTec GmbH (“SphingoTec”) announced today the first published data (1) on the biomarker DPP3 that can predict the evolution of organ function and survival in septic patients. Measured on top of routinely used standard parameters, such as Lactate and Procalcitonin, DPP3 is an early indicator of
WEITERLESEN »

The impact of population-wide rapid antigen testing on SARS-CoV-2 prevalence in Slovakia

  Washington,DC, USA (March 23, 2021) — In Slovakia, in counties subject to two rounds of rapid antigen testing for SARS-CoV-2 where those who tested positive then isolated, the approach helped decrease the prevalence of positive tests by more than 50% in a week – all while primary schools and workplaces remained open. “While it
WEITERLESEN »

Pilot study finds evidence of bartonella infection in schizophrenia patients

  Raleigh, NC, USA (March 23, 2021) — A pilot study from North Carolina State University and the University of North Carolina at Chapel Hill has found evidence of Bartonella infection in the blood of people with schizophrenia and schizoaffective disorder. “Researchers have been looking at the connection between bacterial infection and neuropsychiatric disease for
WEITERLESEN »

Hospitalized COVID-19 patients with obesity are significantly more likely to need ICU care

Study did not find higher risk of death in people with obesity, COVID-19   WASHINGTON, USA (March 20, 2021) — People with obesity who are hospitalized with COVID-19 have a significantly higher rate of ICU admissions and longer duration of ICU stay compared to people with a normal body mass index (BMI), according to a
WEITERLESEN »

Certain mouthwashes might stop COVID-19 virus transmission

A Rutgers study shows two types of mouthwash disrupt SARS-CoV-2 in laboratory   New Brunswick, NJ, USA (March 17, 2021) — Researchers at Rutgers School of Dental Medicine have found evidence that two types of mouthwash disrupt the COVID-19 virus under laboratory conditions, preventing it from replicating in a human cell. The study, published in
WEITERLESEN »

High speed air hand dryers spread contamination more than paper towels

Experiment shows air dryers spread bacteria from poorly washed hands to clothing and surfaces beyond the restroom   NEW YORK, USA (March 17, 2021) — High speed air dryers not only leave more contamination on poorly washed hands compared to paper towels, but during hand drying, they can also spread germs onto clothing, ultimately transferring
WEITERLESEN »

Nurse work environment influences stroke outcomes

  PHILADELPHIA, USA (March 17, 2021) – Stroke remains a leading cause of death worldwide and one of the most common reasons for disability. While a wide variety of factors influence stroke outcomes, data show that avoiding readmissions and long lengths of stay among ischemic stroke patients has benefits for patients and health care systems
WEITERLESEN »

Aspirin use may decrease ventilation, ICU admission and death in COVID-19 patients

Researchers from the George Washington University found that aspirin may have lung-protective effects and reduce the need for mechanical ventilation, ICU admission and in-hospital mortality in hospitalized COVID-19 patients   Washington, DC (March 17, 2021) — George Washington University researchers found low dose aspirin may reduce the need for mechanical ventilation, ICU admission and in-hospital
WEITERLESEN »

Ultrasound has potential to damage coronaviruses, study finds

Simulations show ultrasound waves at medical imaging frequencies can cause the virus’ shell and spikes to collapse and rupture   Cambridge, MA, USA (March 17, 2021) — The coronavirus’ structure is an all-too-familiar image, with its densely packed surface receptors resembling a thorny crown. These spike-like proteins latch onto healthy cells and trigger the invasion
WEITERLESEN »

Full evolutionary journey of hospital superbug mapped for the first time

  Hinxton, Cambridgeshire, UK (March 9, 2021) — Modern hospitals and antibiotic treatment alone did not create all the antibiotic resistant strains of bacteria we see today. Instead, selection pressures from before widespread use of antibiotics influenced some of them to develop, new research has discovered. By using analytical and sequencing technology that has only
WEITERLESEN »

A new predictive model helps identify those at risk for severe COVID-19

Buck scientists analyze data from 3 million people using a smartphone app in the United Kingdom   Novato, CA, USA (March 9, 2021) — Researchers at the Buck Institute analyzed data from the COVID-19 Symptom Tracker app used by 3 million people in the United Kingdom, adding the use of immunosuppressant medication, use of a
WEITERLESEN »

Study reveals new hope for men with common urinary issues

  Leawood, KS, USA (March 9, 2021) — A new systematic review of evidence recommends the use of behavioral self-management treatments for common urinary issues experienced by upwards of 70 percent of older men. Common symptoms include trouble urinating, increased frequency and incontinence. These symptoms can have a substantial negative impact on sleep, social functioning
WEITERLESEN »

Treating incontinence in primary care: A doctor versus mobile app trial

Treating incontinence in primary care: A doctor versus mobile app trial App-based treatment in primary care for urinary incontinence: A pragmatic, randomized controlled trial   Leawood, KS, USA (March 9, 2021) — A mobile app designed to help women manage urinary incontinence was as effective as usual, in-person treatment of incontinence in primary care, according
WEITERLESEN »

After old age, intellectual disability is greatest risk factor for death from COVID-19

A study of national data shows the devastating impact the pandemic has had on those with intellectual disabilities and their caregivers.   PHILADELPHIA, USA (March 5, 2021) — Intellectual disability puts individuals at higher risk of dying earlier in life than the general population, for a variety of medical and institutional reasons. A new study
WEITERLESEN »

New Corona test developed

Researchers develop a low-cost and fast method to detect a COVID-19 infection from a pool of gargle lavage samples   Leipzig, Germany (march 5, 2021) — Quantitative real-time polymerase chain reaction (qPCR) is the most widely used diagnostic method to detect RNA viruses such as SARS-CoV-2. However, it requires expensive laboratory equipment and global shortages
WEITERLESEN »

Smoking cessation drug may treat Parkinson’s in women

Texas A&M researchers have found that that cytisine can reduce dopamine neuron loss, providing a protective effect against the neurodegenerative disorder.   (March 4, 2021) — Texas A&M University College of Medicine ressearchers have recently discovered that cytisine — a smoking cessation drug commonly used in Europe — reduces the loss of dopamine neurons in
WEITERLESEN »

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 February 2021

  Six new medicines recommended for approval Amsterdam, The Netherlands (February 26, 2021) — EMA’s human medicines committee (CHMP) recommended six medicines for approval at its February 2021 meeting. The Committee recommended granting a marketing authorisation for Evrysdi* (risdiplam), the first treatment that can be given orally to patients with certain types of spinal muscular
WEITERLESEN »

Using face masks in the community: first update – Effectiveness in reducing transmission of COVID-19

Using face masks in the community: first update – Effectiveness in reducing transmission of COVID-19   Solna, Sweden (February 15, 2021) — This technical report reviews the evidence that has been accumulated since the emergence of COVID-19, in addition to what has existed on this topic prior to the pandemic, and updates the ECDC opinion
WEITERLESEN »

Difficulties to care for ICU patients caused by COVID-19

  Seville, Espagna (February 10, 2021) — Researchers from the University of Seville’s Nursing Department, with the collaboration of professionals from the ICU at Virgen Macarena University Hospital in Seville, have analysed the key factors in caring for critical COVID-19 patients during the first wave of the pandemic. Their study concludes that nursing care was
WEITERLESEN »

Virtual post-sepsis recovery program may also help recovering COVID-19 patients

  New York, NY, USA (Feb. 10, 2021) — A new paper published online in the Annals of the American Thoracic Society describes a “virtual” recovery program for sepsis patients that may also help post-COVID-19 patients and survivors of other serious illnesses. In “Translating Post-Sepsis Care to Post-COVID Care: The Case for a Virtual Recovery
WEITERLESEN »

‘Sleep hygiene’ should be integrated into epilepsy diagnosis and management

  Children with epilepsy sleep poorly compared to healthy children, and are more likely to experience disruptions such as night terrors, sleep walking or sleep disordered breathing, according to a new study. A team at the University of Birmingham’s Centre for Human Brain Health analysed 19 published studies on sleep and epilepsy in children and
WEITERLESEN »

Case Western Reserve-led team finds that people with dementia at higher risk for COVID-19

  CLEVELAND, Ohio, USA (Feb. 9, 2021) — A study led by Case Western Reserve University researchers found that patients with dementia were at a significantly increased risk for COVID-19–and the risk was higher still for African Americans with dementia. Reviewing electronic health records of 61.9 million adults in the United States, researchers found the
WEITERLESEN »

Cancer leading cause of death among people with diabetes

  London, UK (February 4, 2021) — This is the finding of an 18-year-study of over 300,000 people with diabetes in England, from scientists from Imperial College London and published in the journal The Lancet Diabetes & Endocrinology. Thursday Feb 4th is World Cancer Day. The research, funded by the Wellcome Trust, reveals that between
WEITERLESEN »

Study finds recommended ICU sedatives equally safe, effective

  Nashville, Tennessee, USA (February 2, 2021) — Sedative medications used in intensive care are associated with increased delirium, which is in turn connected with higher medical costs and greater risk of death and ICU-related dementia. A study published today in the New England Journal of Medicine provides the most definitive evidence to date that,
WEITERLESEN »

Guidelines for extracorporeal cardiopulmonary resuscitation in children and adults: New ELSO statements in ASAIO Journal

  (February 1, 2021) — Extracorporeal cardiopulmonary resuscitation (ECPR) is a potentially lifesaving treatment for patients in cardiac arrest when the circulation can’t be restored by conventional CPR. New guidelines for ECPR in adults and children, developed by the Extracorporeal Life Support Organization (ELSO), are presented by the ASAIO Journal, official journal of the American
WEITERLESEN »

Prostate drug associated with lower risk of Parkinson’s disease

  Iowa City, Iowa, USA (February 1, 2021) — Taking a particular type of medication to treat enlarged prostate is associated with a reduced risk of developing Parkinson’s disease, according to a large observational study led by researchers at the University of Iowa, with colleagues in Denmark and China. The findings, published Feb. 1 in
WEITERLESEN »

Genetic screening before prescribing could benefit millions

  Norwich, UK (January 29, 2021) — Four million UK patients could benefit annually from genetic testing before being prescribed common medicines, according to new research from the University of East Anglia (UEA) in collaboration with Boots UK and Leiden University (Netherlands). Researchers looked through 2019 NHS dispensing data across the UK to see how
WEITERLESEN »

Metformin may affect risk of breast cancer in women with type 2 diabetes

  (January 28, 2021) — A study of 44,541 women has found that there appears to be no association between type 2 diabetes and developing breast cancer overall. This may be because most women in the study with type 2 diabetes were taking metformin, a medication widely used to treat type 2 diabetes, whose actions
WEITERLESEN »

Heparin targets coronavirus spike protein, research shows

Common anticoagulant drug could be repurposed for Covid-19 treatment   Liverpool, UK (January 28, 2021) — An international team of researchers led by the Universities of Liverpool and Keele, working with Public Health England, has found that the common anticoagulant drug heparin inhibits the SARS-Cov2 virus spike protein, by reducing the virus’ ability to attach
WEITERLESEN »

How coronavirus damages lung cells within mere hours

Multipronged BU research team finds 18 FDA-approved drugs that could halt coronavirus infection earlier   Boston, Massachusetts; USA (January 28, 2021) — What if scientists knew exactly what impact the SARS-CoV-2 virus had inside our lung cells, within the first few hours of being infected? Could they use that information to find drugs that would
WEITERLESEN »

MEDICAL NEWS

COVID-19 pandemic sees increased consults for alcohol-related GI and liver…
The eyes offer a window into Alzheimer’s disease
Ventilating the rectum to support respiration
Screening for ovarian cancer did not reduce deaths
Fatigue, mood disorders associated with post-COVID-19 syndrome

SCHMERZ PAINCARE

Jedes vierte Kind wünscht bessere Schmerzbehandlung
Lebensqualität von Patienten in der dauerhaften Schmerztherapie mit Opioiden verbessern
Wenn Schmerzen nach einer OP chronisch werden
Deutscher Schmerz- und Palliativtag 2021 – ONLINE: Schmerzmediziner, Politiker und…
Deutscher Schmerz- und Palliativtag 2021 – ONLINE: COVID-19-Pandemie belastet Schmerzpatienten…

DIABETES

Verbände fordern bessere Ausbildung und Honorierung von Pflegekräften für Menschen…
Minimalinvasive Geräte warnen ungenügend vor Unterzuckerung
Typ-1-Diabetes und Hashimoto-Thyreoiditis treten häufig gemeinsam auf
Risikofaktoren für einen schweren COVID-19-Verlauf bei Menschen mit Diabetes
„Wissen was bei Diabetes zählt: Gesünder unter 7 PLUS“ meldet…

ERNÄHRUNG

DGEM plädiert für Screening und frühzeitige Aufbautherapie: Stationäre COVID-19-Patienten oft…
Führt eine vegane Ernährungsweise zu einer geringeren Knochengesundheit?
Regelmässiger Koffeinkonsum verändert Hirnstrukturen
Corona-Erkrankung: Fehl- und Mangelernährung sind unterschätze Risikofaktoren
Gesundheitliche Auswirkungen des Salzkonsums bleiben unklar: Weder der Nutzen noch…

ONKOLOGIE

Krebs – eine unterschätzte finanzielle Herausforderung
Cannabidiol gegen Hirntumore
Assistierte Selbsttötung bei Krebspatienten: Regelungsbedarf und Ermessensspielraum
Leberkrebs: Bei welchen Patienten wirkt die Immuntherapie?
Konferenzbericht vom virtuellen Münchener Fachpresse-Workshop Supportive Therapie in der Onkologie

MULTIPLE SKLEROSE

Neue S2k-Leitlinie für Diagnostik und Therapie der Multiplen Sklerose
Krankheitsbezogenes Kompetenznetz Multiple Sklerose: Stellungnahme zu SARS CoV 2 Impfdaten…
Schwangere mit MS: Schadet Schubbehandlung dem Ungeborenen?
Multiple Sklerose: Ein Sprung sagt mehr, als viele Kreuzchen auf…
Multiple Sklerose: Salzkonsum reguliert Autoimmunerkrankung

PARKINSON

Gangstörungen durch Kleinhirnschädigung beim atypischen Parkinson-Syndrom
Parkinson-Agenda 2030: Die kommenden 10 Jahre sind für die therapeutische…
Gemeinsam gegen Parkinson: bessere Therapie durch multidisziplinäre Versorgung
Neuer Bewegungsratgeber unterstützt Menschen mit M. Parkinson durch Yoga
Covid-19-Prävention: besondere Vorsicht bei Patienten mit der Parkinson-Krankheit